October 3, 2011
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
Appropriations Update: House releases draft spending bill with increases for NIH, NCI
On Thursday, September 29, the House Appropriations Subcommittee on Labor-Health and Human Services (HHS)-Education released a draft fiscal year (FY) 2012 spending bill. Much to the surprise of many in the community and in stark contrast to the recently-approved Senate spending bill, the House Subcommittee has proposed a $1 billion increase (3.3%) for the NIH, for a total FY 2012 funding level of $31.7 billion. This total funding level is equal to that which was proposed by President Obama for FY 2012. NCI would see a $136 million increase over FY 2011, for a total proposed funding level of $5.196 billion. This also is consistent with the President's request. You may recall that last week the Senate approved a spending bill that cut NIH by $190 million, for a proposed FY 2012 funding level of $30.5 billion. Under the Senate proposal, NCI would be cut by $58 million. Please see the full report from AACR.
Cancer Center Seminar Series Presentation
At last week's Seminar Series, Dr. Mark Schluchter reported on highlights and discussion points from an NCI workshop on "Criteria for Use of Omics-Based Predictors in Clinical Trials" he attended earlier this year. If you would like a copy of Dr. Schluchter's presentation, please contact Gillian Todd.
CASE CCC IN THE NEWS
New Technology Offers the Next Generation of Mammography
Hospitals Analyzing the Radiation Risk
MARK YOUR CALENDARS
Cancer Center Seminar Series: Exploring Genetically and Epigenetically Altered Pathways as Therapeutic Targets for Colon Cancer
Friday, October 7
Please join us Friday, October 7 at the next Cancer Center Seminar Series featuring Zhenghe John Wang, PhD. Dr. Wang, Assistant Professor of Genetics at CWRU, will present Exploring Genetically and Epigenetically Altered Pathways as Therapeutic Targets for Colon Cancer.
Graft vs. Host Disease Conference
The Case CCC and the Meredith A. Cowden Foundation are bringing a national educational conference on Graft vs. Host Disease (GvHD) to Cleveland on Friday, November 4, 7:30 am to 5 pm, at the Renaissance Cleveland Hotel. The conference will unite leading specialists in hematology, oncology, bone marrow transplantation and immunology from more than a dozen of the nation's top cancer research centers and educational institutions to present information on cutting-edge research and treatments. Registration (includes CME credits), is $100 for physicians and pharmacists, $75 for nurses and other healthcare professionals and $25 for students. Please make every effort to register and attend.
Patient-Centered Outcomes Research Institute (PCORI) Pilot Projects Grants Program
Applications are now being accepted for the Patient-Centered Outcomes Research Institute (PCORI) Pilot Projects Grants Program. The purpose of this program to inform on PCORI's ongoing development and enhancement of national priorities for patient-centered outcomes research, support the collection of preliminary data that can provide a platform for an evolving research agenda, and support the identification of research methodology to advance PCOR.
LOI Deadline: November 1
Cellular Molecular Imaging of Cancer Pilot Funding: Cancer Microenvironment
The Case CCC is providing seed funding to develop a strong set of integrative cancer biology–molecular imaging projects that enhance interactions between clinical and basic science researchers with members of the Cancer Imaging Program. This funding will support investigative interdisciplinary teams with broad expertise in cancer biology, imaging science, pharmacology, or genetics with opportunities to explore aspects of cancer biology with non-invasive imaging technologies. Open to all Case, CCF and affiliate faculty members with a cancer or molecular imaging research track record.
See the RFA for more information.
Deadline: November 7
Burroughs Wellcome Fund Collaborative Research Travel Grants
The Burroughs Wellcome Fund is accepting applications for Collaborative Research Travel Grants. These awards support PhD candidates, postdoctoral fellows, and faculty researchers traveling to laboratories domestically or internationally to acquire new research techniques, facilitate or begin collaborations, or attend courses. Candidates must hold a PhD or are studying for a PhD in mathematics, physics, chemistry, computer science, statistics, or engineering, and are interested in investigating research opportunities in the biological sciences.
Deadline: December 1
Robert Wood Johnson Foundation Executive Nurse Fellows
Applications are being accepted for the Robert Wood Johnson Foundation Executive Nurse Fellows program, a three-year advanced leadership program for nurses who aspire to lead and shape health care locally and nationally. Fellows strengthen and improve their leadership abilities related to improving health and health care. There will be an optional informational applicant Web conference on November 7. Registration is required.
Deadline: January 18
NEWS FROM NIH
New Technique Identifies First Events in Tumor Development
NIH to Make a Mightier Mouse Resource for Understanding Disease
**All events are open to anyone interested in attending
Physiology and Biophysics Seminar
Hematology and Oncology Division Research Conference
Cancer Center Research in Progress Seminar canceled
Hematology/Oncology Fellows Conference
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ADDITIONAL UPCOMING SEMINARS & EVENTS
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
Pancreatic Cancer Action Network-AACR Innovative Grants
University-Community Partnerships to Improve Urban Health Outcomes
NIH BULLETIN – Notices and Funding Opportunities
NIH Announces the Posting of Frequently Asked Questions (FAQs) applicable to the 2011 revised regulation on the Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought for All NIH-Supported Institutions (NOT-OD-11-121)
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.